List of Excipients in API valganciclovir hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing valganciclovir hydrochloride
Detailed excipient profiles for valganciclovir hydrochloride
Excipient focus: .ALPHA.-TOCOPHEROL
valganciclovir hydrochloride drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: ACACIA
valganciclovir hydrochloride drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing ACACIA
Excipient focus: ANHYDROUS CITRIC ACID
valganciclovir hydrochloride drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valganciclovir hydrochloride | 31722-837 |
| American Health Packaging | valganciclovir hydrochloride | 60687-765 |
| NorthStar RxLLC | valganciclovir hydrochloride | 72603-174 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CELLULOSE, MICROCRYSTALLINE
valganciclovir hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
valganciclovir hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSPOVIDONE
valganciclovir hydrochloride drug variants containing CROSPOVIDONE
valganciclovir hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
valganciclovir hydrochloride drug variants containing FERRIC OXIDE RED
valganciclovir hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FUMARIC ACID
valganciclovir hydrochloride drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| MAJOR PHARMACEUTICALS | valganciclovir hydrochloride | 0904-7419 |
| Novadoz Pharmaceuticals LLC | valganciclovir hydrochloride | 72205-019 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing FUMARIC ACID
Excipient focus: HYPROMELLOSE 2910
valganciclovir hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
valganciclovir hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
valganciclovir hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
valganciclovir hydrochloride drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
valganciclovir hydrochloride drug variants containing MANNITOL
valganciclovir hydrochloride drug variants not containing MANNITOL
Excipient focus: OCTENYLSUCCINIC ACID
valganciclovir hydrochloride drug variants containing OCTENYLSUCCINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing OCTENYLSUCCINIC ACID
Excipient focus: POLYETHYLENE GLYCOL
valganciclovir hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
valganciclovir hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
valganciclovir hydrochloride drug variants containing POLYETHYLENE GLYCOL 4000
valganciclovir hydrochloride drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYSORBATE 80
valganciclovir hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | valganciclovir hydrochloride | 43598-356 |
| Mckesson Corporation DBA SKY Packaginng | valganciclovir hydrochloride | 63739-357 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride | 65862-753 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
valganciclovir hydrochloride drug variants containing POLYVINYL ALCOHOL
valganciclovir hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K30
valganciclovir hydrochloride drug variants containing POVIDONE K30
valganciclovir hydrochloride drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| AvKARE | valganciclovir hydrochloride | 42291-972 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
valganciclovir hydrochloride drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | valganciclovir hydrochloride powder, | 59651-444 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
valganciclovir hydrochloride drug variants containing SACCHARIN SODIUM
valganciclovir hydrochloride drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
valganciclovir hydrochloride drug variants containing SILICON DIOXIDE
valganciclovir hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
valganciclovir hydrochloride drug variants containing SODIUM BENZOATE
valganciclovir hydrochloride drug variants not containing SODIUM BENZOATE
Excipient focus: STEARIC ACID
valganciclovir hydrochloride drug variants containing STEARIC ACID
valganciclovir hydrochloride drug variants not containing STEARIC ACID
Excipient focus: SUCRALOSE
valganciclovir hydrochloride drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| AvKARE | valganciclovir hydrochloride | 42291-972 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing SUCRALOSE
Excipient focus: TALC
valganciclovir hydrochloride drug variants containing TALC
valganciclovir hydrochloride drug variants not containing TALC
Excipient focus: TARTARIC ACID
valganciclovir hydrochloride drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | valganciclovir hydrochloride | 0591-2579 |
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| AvKARE | valganciclovir hydrochloride | 42291-972 |
| Aurobindo Pharma Limited | valganciclovir hydrochloride powder, | 59651-444 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing TARTARIC ACID
Excipient focus: TITANIUM DIOXIDE
valganciclovir hydrochloride drug variants containing TITANIUM DIOXIDE
valganciclovir hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
valganciclovir hydrochloride drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | valganciclovir hydrochloride | 27241-159 |
| >Company | >Ingredient | >NDC |
valganciclovir hydrochloride drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
